<DOC>
	<DOC>NCT01206218</DOC>
	<brief_summary>Evaluation of customized treatment according to BRCA1 assessment in patients with advanced gastric cancer</brief_summary>
	<brief_title>Evaluation of Customized Treatment According to BRCA1 Assessment in Patients With Advanced Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Provision of informed consent Female or male aged 18 years and over Histologic or cytologic confirmation of advanced gastric cancer Stage IIIIV (AJCC 7th) ECOG: 02 Have tumor sample that can be tested for BRCA1 mRNA expression Negative pregnancy test for women of childbearing potential Neutrophile granulocyte greater than 1.5×10^9/L Hemoglobin greater than 10g/dL Platelet greater than 100×10^9/L Serum bilirubin not greater than 1.5x upper limit of reference range (ULRR) ALT or AST not greater than 1.5x ULRR Creatinine clearance no less than 60ml/min Have at least another primary malignant tumor Active infection Chemotherapy with experimental drug within 3 weeks before the start of study therapy Women who are pregnant or breast feeding Weight loss greater 10% within 6 weeks before the start of study therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Gastric Cancer, BRCA1</keyword>
</DOC>